ESC 365 - Future direction for research in Clopidrogel's use in day to day clinical practice.

ESC Premium Access

Future direction for research in Clopidrogel's use in day to day clinical practice.

Session: Still learning of DAPT: Clopidogrel out of the game?

Topic: Drug therapy

Speaker: Professor D. Sibbing (Munich, DE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Dirk Sibbing

Ludwig Maximilians University, Munich (Germany)

9 presentations

7 followers

3 more presentations in this session

State of the art in Clopidogrel response in clinical practice.

Speaker: Professor A. Witkowski (Warsaw, PL)

Results of genotype guided antiplatelet therapy in patients undergone percutaneous coronary intervention with stent

Speaker: Doctor J. Sanchez Ramos (Granada, ES)

Recommendations and levels of evidence underlying the current guidelines of the European Society of Cardiology.

Speaker: Doctor D. Caldeira (Lisbon, PT)

Access the full session

Still learning of DAPT: Clopidogrel out of the game?

Speakers: Professor D. Sibbing, Professor A. Witkowski, Doctor J. Sanchez Ramos, Doctor D. Caldeira

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources